Panagora Asset Management’s Black Diamond Therapeutics BDTX Stock Holding History

Panagora Asset Management’s Portfolio BDTX Stock Details BDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$546K	Buy	+295,172	New	+$722K	﹤0.01%	878

Other funds holding BDTX

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

DIM

DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

JSSH

J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return

BCM

Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return

Panagora Asset Management's BDTX Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 295,172 shares worth $546K. The stake represents ﹤0.01% of the portfolio and ranks #878 among its holdings.

20 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

Panagora Asset Management held 295,172 shares of Black Diamond Therapeutics worth $546K as of Q2 2026.
Black Diamond Therapeutics was a new Panagora Asset Management position in Q2 2026.
Black Diamond Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #878 holding.
20 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.